Regulation
Boston Scientific’s coronary IVL catheter hits primary endpoints in trial
Boston Scientific's Seismiq 4CE Coronary catheter, which uses intravascular lithotripsy (IVL) technology, met primary endpoints in its IDE trial. The company plans to file with the FDA based on these results to seek clearance for the device used in coronary interventions.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network